Alvotech (ALVO) Deferred Taxes (2021 - 2026)
Alvotech (ALVO) posted Deferred Taxes of -$44000.0 for Q1 2026, up 94.73% on a QoQ basis from -$835000.0 in Q3 2025, and up 99.73% year-over-year from -$22029.8 in Q1 2025.
Alvotech (ALVO) Deferred Taxes (2021 - 2026) Analysis & Trends
Alvotech's Deferred Taxes history runs 6 years deep, the most recent figure standing at -$44000.0 for Q1 2026.
- Quarterly Deferred Taxes rose 99.73% year-over-year to -$44000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$39.9 million (down 964.51% YoY) and the FY2023 annual result came in at -$99.3 million, down 160.9% from the prior year.
- Deferred Taxes was -$44000.0 for Q1 2026 at Alvotech, up from -$835000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $14.3 million in Q4 2024 and bottomed at -$99.3 million in Q4 2023.
- A 5-year average of -$17.0 million and a median of -$14.8 million in 2024 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2022 — Deferred Taxes tumbled 14685.06% — and 2024, when it jumped 156.51%.
- Alvotech's Deferred Taxes stood at -$38.1 million in 2022, then sank by 160.9% to -$99.3 million in 2023, then surged by 114.4% to $14.3 million in 2024, then plunged by 105.84% to -$835000.0 in 2025, then surged by 94.73% to -$44000.0 in 2026.
- Business Quant data shows ALVO's Deferred Taxes at -$44000.0 in Q1 2026, -$835000.0 in Q3 2025, and -$22.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,000.00 |
| Sep 30, 2025 | -835,000.00 |
| Jun 30, 2025 | -22.73 Mn |
| Mar 31, 2025 | -16.26 Mn |
| Dec 31, 2024 | 14.30 Mn |
| Sep 30, 2024 | -13.36 Mn |
| Jun 30, 2024 | 11.57 Mn |
| Mar 31, 2024 | -6.44 Mn |
| Dec 31, 2023 | -99.32 Mn |
| Jun 30, 2023 | -20.47 Mn |
| Mar 31, 2023 | -29.38 Mn |
| Dec 31, 2022 | -38.07 Mn |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | -18.16 Mn |
| Dec 31, 2021 | 261,000.00 |
| Sep 30, 2021 | -22.04 Mn |